ⓘ Featured image details: CureFit co-founders: Mukesh Bansal (L) and Ankit Nagori (R); Credits: Forbes
Healthcare and wellness startup Curefit today raised INR 832 crore (around $110 million) in its second Series D funding round led by Singapore’s Temasek, with participation from Unilever Venture Holdings and Ascent Capital. The following round came after several quarters of negotiations of CureFit with Softbank Vision Fund which did not go through.
The latest funding deal has valued the company around INR 4,300 crores (around $570 million). CureFit last raised $120 million in June 2019 from a number of investors including Accel, Chiratae, Kalaari, and Oaktree which value the company at INR 3,700 crore.
JOIN US TO STAY UPDATED ON YOUR FAVORITE MESSENGER APP!
ⓘ As part of our ongoing support for startups and SMEs, LAFFAZ Media publishes feature and resource articles that may include references and links to external websites. These inclusions are selected at our editorial discretion to provide valuable information to our readers. LAFFAZ Media does not control, endorse, or assume responsibility for the content or practices of external websites. For more details, please refer to our Terms and Conditions.
